Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hay

Showing results (381-390 of 423) with videos related to

Pageof 43
Sort By:
Current Oncology (Toronto, Ont.)|May 3, 2019
The economic impact of the transition from branded to generic oncology drugsW Y Cheung, E A Kornelsen, N Mittmann, et al.
Leukemia & Lymphoma|September 18, 2015
A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191Annette E Hay, Alli Murugesan, Ashley M DiPasquale, et al.
Leukemia & Lymphoma|March 11, 2020
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemiaSarit Assouline, Lilian Amrein, Raquel Aloyz, et al.
Leukemia & Lymphoma|January 18, 2024
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practiceVersha Banerji, Andrew Aw, Nicole Laferriere, et al.
The Journal of Molecular Diagnostics : JMD|August 8, 2021
Validation, Implementation, and Clinical Impact of the Oncomine Myeloid Targeted-Amplicon DNA and RNA Ion Semiconductor Sequencing AssayChristina K Ferrone, Henry Wong, Laura Semenuk, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 1999
Etiology and outcome for 295 patients with acute liver failure in the United StatesF V Schiodt, E Atillasoy, A O Shakil, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
Recurrence of primary sclerosing cholangitis following liver transplantationI W Graziadei, R H Wiesner, K P Batts, et al.
Blood Neoplasia|June 8, 2026
A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18)Sarit Assouline, Anca Prica, Diego Villa, et al.
Leukemia & Lymphoma|October 11, 2018
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†Tony Reiman, Kerry J Savage, Michael Crump, et al.
Rheumatology (Oxford, England)|September 9, 2004
Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee--the MOVE consensusE Roddy, W Zhang, M Doherty, et al.
Pageof 43

Showing results (381-390 of 423) with videos related to

Sort By:
Pageof 43
Current Oncology (Toronto, Ont.)|May 3, 2019
The economic impact of the transition from branded to generic oncology drugsW Y Cheung, E A Kornelsen, N Mittmann, et al.
Leukemia & Lymphoma|September 18, 2015
A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191Annette E Hay, Alli Murugesan, Ashley M DiPasquale, et al.
Leukemia & Lymphoma|March 11, 2020
IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemiaSarit Assouline, Lilian Amrein, Raquel Aloyz, et al.
Leukemia & Lymphoma|January 18, 2024
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practiceVersha Banerji, Andrew Aw, Nicole Laferriere, et al.
The Journal of Molecular Diagnostics : JMD|August 8, 2021
Validation, Implementation, and Clinical Impact of the Oncomine Myeloid Targeted-Amplicon DNA and RNA Ion Semiconductor Sequencing AssayChristina K Ferrone, Henry Wong, Laura Semenuk, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 1999
Etiology and outcome for 295 patients with acute liver failure in the United StatesF V Schiodt, E Atillasoy, A O Shakil, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
Recurrence of primary sclerosing cholangitis following liver transplantationI W Graziadei, R H Wiesner, K P Batts, et al.
Blood Neoplasia|June 8, 2026
A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18)Sarit Assouline, Anca Prica, Diego Villa, et al.
Leukemia & Lymphoma|October 11, 2018
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†Tony Reiman, Kerry J Savage, Michael Crump, et al.
Rheumatology (Oxford, England)|September 9, 2004
Evidence-based recommendations for the role of exercise in the management of osteoarthritis of the hip or knee--the MOVE consensusE Roddy, W Zhang, M Doherty, et al.
Pageof 43